首页> 外文期刊>Journal of Ophthalmology >Under-the-Flap Crosslinking and LASIK in Early Ectasia with Hyperopic Refractive Error
【24h】

Under-the-Flap Crosslinking and LASIK in Early Ectasia with Hyperopic Refractive Error

机译:远视眼屈光不正的早期蜕膜皮瓣下交联和LASIK

获取原文
           

摘要

Purpose. To present safety, efficacy, and early results of a new combinational treatment for early corneal ectasia with hyperopic refractive error aimed to reinstate emmetropia and stabilize cornea. Method. This is a retrospective case series. All surgeries were performed at the Beirut Eye Specialist Hospital, Lebanon. Surgical procedure consisted of (1) lifting flap (post-LASIK ectasia)/creation of corneal flap (keratoconus), (2) application of excimer laser ablation to correct refractive error, (3) loose repositioning of flap, (4) under-the-flap irrigation with riboflavin 0.1% dextran solution, and (5) application of UVA light. Results. A total of 7 eyes (4 patients; mean age 24.25 years; all male) were included. 2 patients had early keratoconus, and 2 patients had early post-LASIK ectasia. Pretreatment vs. last postoperative follow-up visit (mean 11.25 months; range 6–15 months) UDVA (logMAR), spherical equivalent (SE) (D), astigmatism (D), and central pachymetry (μm) were 0.35 ± 0.18 vs. 0.05 ± 0.07, ; ?0.81 ± 0.67 vs. ?0.46 ± 0.57, ; 2.46 ± 0.53 vs. 0.68 ± 0.28, ; and 547 ± 58 vs. 536 ± 49, , respectively. In all eyes, BCVA was 0.1?logMAR or better before and after treatment. No eye showed a decrease in BCVA. Two eyes of one patient had an epithelial ingrowth, which was removed in one case. Follow-up results showed no major complications and no progression of corneal ectasia. Conclusion. Early results showed that under-the-flap CXL with excimer laser correction is an effective treatment for early hyperopic keratectasia, with the advantage of rapid recovery, postoperative corneal stability, and no epithelial healing complications. The procedure seems to bear a risk for postoperative epithelial growth into the flap interface.
机译:目的。为了展示安全性,有效性和早期联合治疗远视屈光不正的角膜扩张的新结果,旨在恢复正视和稳定角膜。方法。这是一个回顾性案例系列。所有手术均在黎巴嫩贝鲁特眼科专科医院进行。外科手术包括:(1)提起皮瓣(LASIK术后扩张)/角膜皮瓣(圆锥角膜)创生;(2)应用准分子激光消融术以矫正屈光不正;(3)皮瓣松动复位;(4)用核黄素0.1%葡聚糖溶液进行皮瓣灌溉,以及(5)施加UVA光。结果。包括总共7眼(4例;平均年龄24.25岁;全部为男性)。 2例患有圆锥角膜早期,2例患有LASIK术后早期扩张。术前vs术后最后一次随访(平均11.25个月;范围6–15个月)UDVA(logMAR),球当量(SE)(D),散光(D)和中心测厚法(μm)为0.35±0.18 vs 0.05±0.07 ,; 0.81±0.67对0.46±0.57 ,; 2.46±0.53和0.68±0.28,;分别为547±58和536±49。在所有眼睛中,治疗前后BCVA为0.1?logMAR或更高。没有眼睛显示BCVA降低。一名患者的两只眼睛上皮向内生长,其中一例已摘除。随访结果显示无严重并发症且角膜扩张没有进展。结论。早期结果表明,采用准分子激光矫正的皮瓣下CXL是早期远视角化病的有效治疗方法,具有恢复快,术后角膜稳定,无上皮愈合并发症的优势。该手术似乎有术后上皮生长进入皮瓣界面的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号